IOVANCE BIOTHERAPEUTICS, INC. Quarterly Cost of Revenue in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2023 to Q3 2024.
  • Iovance Biotherapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $39.8M, a 818% increase year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $39.8M +$35.5M +818% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $31.4M +$29.3M +1430% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.26M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $4.34M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.05M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.